Prognostic factors of mid-term clinical outcome in congestive heart failure patients discharged after acute decompensation

Archives of Medical Science

Volumn 8, Issue 3, 2012, Pages 462-470

  Feola, Mauro ^a   Lombardo, Enrico ^a   Testa, Marzia ^b   Avogadri, Enrico ^a   Piccolo, Salvatore ^a   Vado, Antonello ^c  

^a Ospedale SS Trinita'   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

Congestive heart failure; Natriuretic peptide; Prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART TRANSPLANTATION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; HYDRATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; WATER CONTENT;

EID: 84863884267     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.29523     Document Type: Article

References (33)

1. Swedberg K, Cleland J, Dargie H, et al. Guidilines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-40.
2. Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ; ADHERE Scientific Advisory Committee. Risk stratification for in-hospital mortality in acutely decompensated heart failure. JAMA 2005; 293: 572-80.
3. Boland DG, Abraham WT. Natriuretic peptides in heart failure. Congestive Heart Fail 1998; 4: 23-33. (Pubitemid 28185699)
4. McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351: 9-13. (Pubitemid 28020159)
5. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-7. (Pubitemid 34764819)
6. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002; 105: 2392-7. (Pubitemid 34556391)
7. Latini R, Masson S, Anand I, et al.; Val-HeFT Investigators. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J 2004; 25: 292-9. (Pubitemid 38295437)
8. Feola M, Aspromonte N, Canali C, et al. Prognostic value of plasma brain natriuretic peptide, urea nitrogen and creatinine in outpatients > 70 years of age with heart failure. Am J Cardiol 2005; 96: 705-9. (Pubitemid 41207318)
9. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655-63. (Pubitemid 38364624)
10. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of CHF. The Framingham study. N Engl J Med 1971; 285: 1442-6.
11. Peacock WF. Rapid optimization: strategies for optimal care of decompensated congestive heart failure patients in the emergency department. Rev Cardiovasc Med 2003; 3: S41-8.
12. Sahn DJ, Demaria A, Kisslo J, Weyman A. The committee on M mode standardisation of the American Society of Echocardiography: recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83. (Pubitemid 9091990)
13. Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998; 32: 865-75. (Pubitemid 28459571)
14. Agostoni PG, Cattadori G, Apostolo A, et al. Non-invasive measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evolution. J Am Coll Cardiol 2005; 46: 1779-83.
15. ATS Statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. Am J Respir Crit Care Med 2002; 166: 111-7.
16. Bioelectrical impedance analysis in body composition measurement. Proceeding of a National Institutes of Health Technology Assessment Conference. Bethesda, Maryland, December 12-14, 1994. Am J Clin Nutr 1996; 64 Suppl: 387S-532S.
17. Piccoli A. Patterns of bioelectrical impedance vector analysis: learning from electrocadiography and forgetting electric circuit models. Nutrition 2002; 18: 520-1. (Pubitemid 34586809)
18. Di Lenarda A, Scherillo M, Maggioni AP, et al. Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of words. The TEMISTOCLE study. Am Heart J 2003; 146: E12.
19. Hernandez AF, Greiner MA, Fonarow GC, et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA 2010; 303: 1716-22.
20. Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004; 43: 635-41. (Pubitemid 38229537)
21. Maisel AS. Practical approaches to treating patients with acute decompensated heart failure. J Card Fail 2001; 7 (Suppl 1): 13-7. (Pubitemid 33732174)
22. RoncoC, McCullogh P, Anker SD, et al. Cardio-renal syndromes: report from the consensus Conference of the Acute Dialysis Quality Initiative. Eur Heart J 2010; 6: 703-11.
23. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (Suppl 2): S1-266.
24. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wignesrawan JR, Wynne J. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 2007; 13: 422-30. (Pubitemid 47179911)
25. Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ; ADHERE Scientific Advisory Commettee. Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis. JAMA 2005; 293: 572-80. (Pubitemid 40171239)
26. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008; 29: 2388-442.
27. Eriksson SV, Caidahl K, Hamsten A, de Faire U, Rehnquist N, Lindvall K. Long-term prognostic significance of M mode echocardiography in young men after myocardial infarction. Br Heart J 1995; 74: 124-30.
28. Sachero A, Casazza F, Recalcati F, et al. Clinical and prognostic significance of echocardiographic parameters in dilated cardiomyopathy: a prospective study on 255 patients. The Italian Multicenter Study of Cardiomyopathies Group. G Ital Cardiol 1992; 22: 1077-90.
29. Whalley GA, Gamble G, Doughty R. The prognostic significance of restrictive filling associate with heart failure: a meta-analysis. Int J Cardiol 2007; 116: 70-7. (Pubitemid 46227608)
30. Whalley GA, Gamble G, Doughty R. Restrictive diastolic filling predicts death post acute myocardial infarction: a meta-analysis. Heart 2006; 92: 1588-94. (Pubitemid 44629161)
31. Feola M, Aspromonte N, Milani L, et al. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern. J Card Fail 2008; 14: 420-5. (Pubitemid 351749837)
32. Cattadori G, Salvioni E, Gondoni E, Agostoni PG. Evaluation of noninvasive exercise cardiac output determination in chronic heart failure pateints: a proposal of a new diagnostic and prognostic method. J Cardiovasc Med 2010; 12: 19-27.
33. Passantino A, Lagioia R, Mastropasqua F, Scrutinio D. Short-term change in distance walked in 6 min is an indicator of outcome in patients with chronic heart failure in clinical practice. J Am Coll Cardiol 2006; 48: 99-105. (Pubitemid 43929226)